The Peter Attia Drive

Podbit · The Peter Attia Drive

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D.

Explore episode Jun 22, 2026
Health & Fitness
Mitochondrial Replacement Therapy: Battery Swap, Not Engine Replacement

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility,… · Jun 22, 2026 Health & Fitness

Mitochondrial replacement therapy swaps the cytoplasm around the nucleus but doesn't fix the chromosomes — the actual source of age-related infertility. Clinics in North Cyprus and Greece are marketing this as egg rejuvenation. It isn't. The engine is still old; you just changed the battery.

Where this was said

Emerging fertility technologies: mitochondrial replacement, ovarian tissue preservation, stem-cell-derived eggs, and current limitations

At 1:33:40 · chapter starts 1:32:29

Peter invites Tomioka to survey the technology horizon for women who want to use their own genetic material at advanced age. Mitochondrial replacement therapy, developed for mitochondrial disease and published in the New England Journal of Medicine by a Newcastle group, transfers nuclear material (pronuclei) into an enucleated donor egg to replace defective mitochondria — but the chromosomes, the actual source of age-related aneuploidy, remain the patient's own. Tomioka bluntly labels clinics in North Cyprus and Greece selling this as 'egg rejuvenation' as misleading: 'It's a battery swap for the egg, but you're not changing the engine.' Ovarian cortex cryopreservation — freezing a slice of ovarian tissue in one's 30s and reimplanting it at 45 — is theoretically capable of postponing menopause by 10 to 15 years but lacks clinical data and is arguably inferior to standard hormone replacement therapy. The most transformative technology on the horizon is stem-cell-derived eggs: pluripotent stem cells converted into functional oocytes. It has been demonstrated in mice with normal offspring. Tomioka estimates clinical reality is about 10 years away, at which point age becomes largely irrelevant to fertility. He closes with a nuanced caution about IVF itself: Louise Brown, the first IVF baby, is only 48. Epigenetic effects of fertilization outside the fallopian tube remain uncharacterized, and selection bias makes epidemiological studies hard to interpret.

Health & Fitness
Stem-Cell-Derived Eggs: The Technology That Could Change Everything

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility,… · Jun 22, 2026 Health & Fitness

If pluripotent stem cells can be reliably converted into functional, chromosomally normal eggs, age becomes irrelevant to fertility. It has been done in mice with normal offspring. Larger animals are next. Renato Tomioka estimates 10 years to clinical reality — and when it arrives, egg freezing becomes obsolete.

Health & Fitness
IVF Is Brand New Technology — And We Don't Know All the Consequences

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility,… · Jun 22, 2026 Health & Fitness

The first IVF baby was born in 1978. Louise Brown is 48. We have no idea what IVF-conceived people look like at 60 or 70. There may be epigenetic effects from fertilization outside the fallopian tube that we simply cannot yet measure. For couples who can conceive naturally, Tomioka still recommends trying.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.